Last 150.25 INR
Change Today +0.95 / 0.64%
Volume 2.3M
DISH On Other Exchanges
Symbol
Exchange
Natl India
As of 7:05 AM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

dishman pharmaceuticals & ch (DISH) Snapshot

Open
150.40
Previous Close
149.30
Day High
154.55
Day Low
146.20
52 Week High
07/22/14 - 159.80
52 Week Low
08/2/13 - 37.05
Market Cap
12.1B
Average Volume 10 Days
1.7M
EPS TTM
13.54
Shares Outstanding
80.7M
EX-Date
08/21/14
P/E TM
11.1x
Dividend
1.20
Dividend Yield
0.80%
Current Stock Chart for DISHMAN PHARMACEUTICALS & CH (DISH)

Related News

No related news articles were found.

dishman pharmaceuticals & ch (DISH) Related Businessweek News

No Related Businessweek News Found

dishman pharmaceuticals & ch (DISH) Details

Dishman Pharmaceuticals and Chemicals Limited provides contract research and manufacturing services to the pharmaceutical industry worldwide. It offers contract services, including process development, process optimization, manufacture for late stage clinical, and commercial supply services. The company also engages in the manufacture and marketing of bulk drugs, intermediates, quaternary compounds (Quats), and specialty chemicals. Its products include various vitamins and chemical products, such as Vitamin D2, Vitamin D3, Vitamin D analogues, cholesterol, and lanolin related products; and specialty chemicals, including ammonium and phosphonium Quats, phosphoranes and wittig reagents, bulk active pharmaceutical ingredients and intermediates, phase transfer catalysts, fine chemicals, and outsourced products for the pharmaceutical, cosmetic, and related industries. The company also offers a range of antiseptics and disinfectants, including disinfectants for surgical instrumentation, hand and body wash sanitizers and antiseptics, pre and post-operative surgical scrubs, and antimicrobial washes for healthcare and related industries. Dishman Pharmaceuticals and Chemicals Limited was incorporated in 1983 and is headquartered in Ahmedabad, India.

Founded in 1983

dishman pharmaceuticals & ch (DISH) Top Compensated Officers

Chairman, Managing Director and Member of Sha...
Total Annual Compensation: 50.9M
Managing Director and Whole-Time Director
Total Annual Compensation: 12.0M
Whole-Time Director
Total Annual Compensation: 12.0M
Compensation as of Fiscal Year 2013.

dishman pharmaceuticals & ch (DISH) Key Developments

Dishman Pharmaceuticals and Chemicals Ltd. Recommends Final Dividend for the Financial Year 2013-2014

Dishman Pharmaceuticals and Chemicals Ltd. announced that at the SBM held on May 28, 2014, the directors recommended the final dividend at 60% (i.e. INR 1.20 per equity share of 2.00 each) on the paid-up equity share capital of the company.

Dishman Pharmaceuticals and Chemicals Ltd. - Shareholder/Analyst Call

Dishman Pharmaceuticals and Chemicals Ltd. - Shareholder/Analyst Call

Dishman Pharmaceuticals and Chemicals Ltd. Reports Unaudited Standalone and Consolidated Earnings Results for the Fourth Quarter and Audited Standalone and Consolidated Earnings Results for the Full Year Ended March 31, 2014

Dishman Pharmaceuticals and Chemicals Ltd. reported unaudited standalone and consolidated earnings results for the fourth quarter and audited standalone and consolidated earnings results for the full year ended March 31, 2014. For the quarter, on standalone basis, the company reported net sales/income from operations of INR 1,568.049 million compared to INR 1,621.038 million a year ago. Profit from operations before other income finance costs and exceptional items was INR 592.689 million compared to INR 602.105 million a year ago. Profit from ordinary activities before tax was INR 928.027 million compared to INR 601.256 million a year ago. Net profit for the period was INR 697.946 million compared to INR 398.209 million a year ago. Basic and diluted earnings per share before and after extraordinary items were INR 8.65 compared to INR 4.93 a year ago. For the year, on standalone basis, the company reported net sales/income from operations of INR 4,719.927 million compared to INR 4,835.810 million a year ago. Profit from operations before other income finance costs and exceptional items was INR 1,320.759 million compared to INR 1,338.438 million a year ago. Profit from ordinary activities before tax was INR 1,188.364 million compared to INR 947.000 million a year ago. Net profit for the period was INR 867.866 million compared to INR 631.751 million a year ago. Basic and diluted earnings per share before and after extraordinary items were INR 10.75 compared to INR 7.83 a year ago. For the quarter, on consolidated basis, the company reported net sales/income from operations of INR 4,006.520 million compared to INR 3,454.563 million a year ago. Profit from operations before other income finance costs and exceptional items was INR 585.840 million compared to INR 515.538 million a year ago. Profit from ordinary activities before tax was INR 504.355 million compared to INR 453.715 million a year ago. Net profit for the period was INR 225.591 million compared to INR 185.712 million a year ago. Basic and diluted earnings per share before and after extraordinary items were INR 2.80 compared to INR 2.30 a year ago. For the year, on consolidated basis, the company reported net sales/income from operations of INR 13,732.375 million compared to INR 12,675.667 million a year ago. Profit from operations before other income finance costs and exceptional items was INR 2,237.740 million compared to INR 2,079.220 million a year ago. Profit from ordinary activities before tax was INR 1,563.652 million compared to INR 1,452.436 million a year ago. Profit from ordinary activities after tax was INR 1,002.532 million compared to INR 568.013 million a year ago. Profit for the period was INR 1,092.352 million compared to INR 1,002.532 million a year ago. Basic and diluted earnings per share before and after extraordinary items were INR 13.54 compared to INR 12.42 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DISH:IN 150.25 INR +0.95

DISH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Divi's Laboratories Ltd 1,498 INR -2.25
Jubilant Life Sciences Ltd 183.65 INR -5.75
Piramal Enterprises Ltd 623.35 INR -14.85
Shasun Pharmaceuticals Ltd 163.00 INR -0.65
Torrent Pharmaceuticals Ltd 694.60 INR +4.65
View Industry Companies
 

Industry Analysis

DISH

Industry Average

Valuation DISH Industry Range
Price/Earnings 11.0x
Price/Sales 0.9x
Price/Book 1.0x
Price/Cash Flow 5.5x
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DISHMAN PHARMACEUTICALS & CH, please visit www.dishmangroup.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.